Cross Icon
Cross Icon

Gmp Grade Human Interleukin2 Il2 Tender in USA - 144816092

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a Gmp Grade Human Interleukin2 Il2 from Acrobiosystems Inc in the USA. This Tender notice was published on 09 Jul 2026 and is scheduled to close on 17 Jul 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 144816092, while the tender notice number is 26-006951 and Registering on the platform.

Expired Tender

Procurement Summary

Country: USA

Summary: Gmp Grade Human Interleukin2 Il2 from Acrobiosystems Inc

Deadline: 17 Jul 2026

Posting Date: 09 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 144816092

Document Ref. No.: 26-006951

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Title: GMP Grade Human Interleukin-2 (IL-2) from ACROBiosystems Inc.
Notice ID (POTS): 26-006951
Product Service Code (PSC): 6505 - Drugs and Biologicals
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: National Institutes of Health
Clinical Center
Bethesda, MD 20892
Description
This Notice of Intent (NOI) is issued for informational purposes only and does not constitute a Request for Quotations (RFQ). The Government does not intend to solicit competitive quotations for this requirement.
The National Institutes of Health (NIH), Clinical Center, Office of Acquisitions and Logistics Management (OALM), intends to award a sole source, firm-fixed-price purchase order to ACROBiosystems Inc., 1 Innovation Way, Suite 302, Newark, DE 19711, for the procurement of fifteen (15) vials of CytoPak GMP Human IL-2 Protein (Part Number: GMP-L02H14GB01), including shipping. The supplies support FDA-regulated cell and gene therapy manufacturing activities performed by the Center for Cellular Engineering (CCE).
Background
The Center for Cellular Engineering manufactures cell and gene therapies for NIH clinical trials. These FDA-regulated manufacturing processes require all components and materials to be validated to ensure product safety, quality, and consistency. The CytoPak GMP Human IL-2 Protein manufactured by ACROBiosystems has been validated for use in CCE's approved manufacturing processes. Substituting another manufacturer's product would require extensive process revalidation, resulting in significant cost and schedule impacts. During revalidation, patient treatment could be delayed, potentially causing disease progression that renders patients ineligible for clinical trials. Consequently, delaying this procurement would not be in the best interest of either the Government or the patients.
Sole Source Rationale
ACROBiosystems Inc. is the onl...
Notice ID: 26-006951

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health olao

Product Service Code: 6505 - drugs and biologicals

NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Inactive Dates: jul 18, 2026

Inactive Policy: manual

Documents

 Tender Notice


Corresponding Contract Award Notice

No Contract Award Notice found for this tender. Please try using the Contract Award Search Page.


Request Demo
GiZ Tenders India

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA


Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?